Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 1
2014 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Intravenous nicardipine dosing for blood pressure lowering in acute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study.
Koga M, Arihiro S, Hasegawa Y, Shiokawa Y, Okada Y, Kimura K, Furui E, Nakagawara J, Yamagami H, Kario K, Okuda S, Tokunaga K, Takizawa H, Takasugi J, Sato S, Nagatsuka K, Minematsu K, Toyoda K; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study Investigators. Koga M, et al. J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2780-2787. doi: 10.1016/j.jstrokecerebrovasdis.2014.06.029. Epub 2014 Oct 12. J Stroke Cerebrovasc Dis. 2014. PMID: 25314943
BACKGROUND: Intravenous nicardipine is commonly used to reduce elevated blood pressure in acute intracerebral hemorrhage (ICH). We determined factors associated with nicardipine dosing and the association of dose with clinical outcomes in hyperacute ICH. ...CONCLUSIONS: Ni …
BACKGROUND: Intravenous nicardipine is commonly used to reduce elevated blood pressure in acute intracerebral hemorrhage (ICH). We de …
Prothrombin complex concentrate administration for bleeding associated with non-vitamin K antagonist oral anticoagulants: The SAMURAI-NVAF study.
Yoshimura S, Sato S, Todo K, Okada Y, Furui E, Matsuki T, Yamagami H, Koga M, Takahashi JC, Nagatsuka K, Arihiro S, Toyoda K; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study Investigators. Yoshimura S, et al. J Neurol Sci. 2017 Apr 15;375:150-157. doi: 10.1016/j.jns.2017.01.041. Epub 2017 Jan 15. J Neurol Sci. 2017. PMID: 28320118
Patients received a median of 1000IU or 16IU/kg of PCC. Before and 1h after PCC administration, the median PT-INR changed from 1.41 to 1.09 (p<0.05) and median aPTT changed from 35.4 to 38.0s (p=0.39). ...
Patients received a median of 1000IU or 16IU/kg of PCC. Before and 1h after PCC administration, the median PT-INR changed from 1.41 t …
Nationwide survey of antihypertensive treatment for acute intracerebral hemorrhage in Japan.
Koga M, Toyoda K, Naganuma M, Kario K, Nakagawara J, Furui E, Shiokawa Y, Hasegawa Y, Okuda S, Yamagami H, Kimura K, Okada Y, Minematsu K; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study Investigators. Koga M, et al. Hypertens Res. 2009 Sep;32(9):759-64. doi: 10.1038/hr.2009.93. Epub 2009 Jun 26. Hypertens Res. 2009. PMID: 19557007
Questionnaires regarding antihypertensive treatment (AHT) strategies were sent to neurosurgeons, neurologists and others responsible for ICH management in 1424 hospitals. Of 600 respondents, 550 (92%) worked at hospitals wherein acute ICH patients are managed …
Questionnaires regarding antihypertensive treatment (AHT) strategies were sent to neurosurgeons, neurologists and others responsible for ICH …
Nationwide survey of neuro-specialists' opinions on anticoagulant therapy after intracerebral hemorrhage in patients with atrial fibrillation.
Maeda K, Koga M, Okada Y, Kimura K, Yamagami H, Okuda S, Hasegawa Y, Shiokawa Y, Furui E, Nakagawara J, Kario K, Nezu T, Minematsu K, Toyoda K; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study Investigators. Maeda K, et al. J Neurol Sci. 2012 Jan 15;312(1-2):82-5. doi: 10.1016/j.jns.2011.08.017. Epub 2011 Aug 27. J Neurol Sci. 2012. PMID: 21875722
PURPOSE: A nationwide survey was conducted regarding anticoagulant therapy in patients with acute intracerebral hemorrhage (ICH) on warfarin with nonvalvular atrial fibrillation (NVAF). ...CONCLUSION: A large majority of respondents responsible for ICH management st …
PURPOSE: A nationwide survey was conducted regarding anticoagulant therapy in patients with acute intracerebral hemorrhage (ICH) on w …